Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chamouard P., Baumann R., Thomas G., Weill J. P. Intérêt de la dapsone dans le traitement des manifestations digestives du purpura rhumatoïde de l'adulte. Ann Med Interne (Paris) 1987;138(8):599–600. [PubMed] [Google Scholar]
- Hoffbrand B. I. Dapsone in Henoch-Schönlein purpura--worth a trial. Postgrad Med J. 1991 Nov;67(793):961–962. doi: 10.1136/pgmj.67.793.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Knight J. F. The rheumatic poison: a survey of some published investigations of the immunopathogenesis of Henoch-Schönlein purpura. Pediatr Nephrol. 1990 Sep;4(5):533–541. doi: 10.1007/BF00869841. [DOI] [PubMed] [Google Scholar]
- Ledermann J. A., Hoffbrand B. I. Dapsone in allergic vasculitis: its use in Henoch-Schönlein disease following vaccination. J R Soc Med. 1983 Jul;76(7):613–614. doi: 10.1177/014107688307600717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Melsom R., Harboe M., Myrvang B., Godal T., Belehu A. Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy. Clin Exp Immunol. 1982 Feb;47(2):225–233. [PMC free article] [PubMed] [Google Scholar]
- Ruzicka T., Wasserman S. I., Soter N. A., Printz M. P. Inhibition of rat mast cell arachidonic acid cyclooxygenase by dapsone. J Allergy Clin Immunol. 1983 Oct;72(4):365–370. doi: 10.1016/0091-6749(83)90501-8. [DOI] [PubMed] [Google Scholar]